Studying how metabolic networks are affected by PHOSPHO1 inhibition—particularly when comparing healthy patients to those with diabetes or obesity—could affect disease understanding, diagnosis, and treatment methods. Here, PHOSPHO1 is linked to diabetes mellitus.